HPC
DXCM icon

HM Payson & Co’s DexCom DXCM Stock Holding History

HM Payson & Co’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-525
Closed -$34.8K – 1154
2025
Q4 		$34.8K Hold
525
– – ﹤0.01% 761
2025
Q3 		$35.3K Hold
525
– – ﹤0.01% 753
2025
Q2 		$45.8K Hold
525
– – ﹤0.01% 662
2025
Q1 		$35.9K Sell
525
-275
-34% -$22.4K ﹤0.01% 697
2024
Q4 		$62.2K Sell
800
-330
-29% -$24.4K ﹤0.01% 608
2024
Q3 		$75.8K Sell
1,130
-278
-20% -$22.8K ﹤0.01% 569
2024
Q2 		$160K Sell
1,408
-372
-21% -$47K ﹤0.01% 435
2024
Q1 		$247K Buy
1,780
+100
+6% +$12.6K ﹤0.01% 364
2023
Q4 		$208K Buy
1,680
+200
+14% +$20.4K ﹤0.01% 376
2023
Q3 		$138K Buy
1,480
+116
+9% +$13.1K ﹤0.01% 435
2023
Q2 		$175K Buy
1,364
+200
+17% +$24.2K ﹤0.01% 389
2023
Q1 		$135K Hold
1,164
– – ﹤0.01% 426
2022
Q4 		$132K Buy
1,164
+24
+2% +$2.63K ﹤0.01% 427
2022
Q3 		$92K Hold
1,140
– – ﹤0.01% 480
2022
Q2 		$85K Hold
1,140
– – ﹤0.01% 492
2022
Q1 		$146K Buy
1,140
+60
+6% +$6.56K ﹤0.01% 437
2021
Q4 		$145K Sell
1,080
-120
-10% -$17.2K ﹤0.01% 441
2021
Q3 		$164K Hold
1,200
– – ﹤0.01% 416
2021
Q2 		$128K Hold
1,200
– – ﹤0.01% 444
2021
Q1 		$108K Hold
1,200
– – ﹤0.01% 471
2020
Q4 		$111K Sell
1,200
-1,008
-46% -$90K ﹤0.01% 459
2020
Q3 		$228K Buy
2,208
+1,008
+84% +$105K 0.01% 340
2020
Q2 		$122K Hold
1,200
– – ﹤0.01% 412
2020
Q1 		$81K Buy
+1,200
New +$74.7K ﹤0.01% 425

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HM Payson & Co's DXCM Position: Q1 2026 in Review

HM Payson & Co sold out of DexCom (DXCM) in Q1 2026, closing a stake of 525 shares — an estimated $34.8K sold.

HM Payson & Co first reported a position in DXCM in Q1 2020 and held it in 24 quarters. The position peaked at $247K in Q1 2024. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • HM Payson & Co reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • HM Payson & Co sold 525 DexCom shares in Q1 2026, an estimated $34.8K.
  • HM Payson & Co first reported a position in DexCom in Q1 2020 and held it in 24 quarters.
  • HM Payson & Co's DexCom position peaked at $247K in Q1 2024.
  • 960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on HM Payson & Co's 13F filing for Q1 2026, filed 13 Apr 2026.